ClinicalTrials.Veeva
Menu

Find clinical trials for Kidney Disease in Nashville, TN

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Kidney Diseases
Chronic Renal Insufficiency
Chronic Kidney Failure
Renal Insufficiency
IGA Glomerulonephritis
Renal Cell Carcinoma
Diabetes Mellitus

Kidney Disease trials near Nashville, TN, USA:

Status recently updated

A Study of REACT in Subjects With Type 2 Diabetes Mellitus and Chronic Kidney Disease

of up to 2 REACT injections given 3 months (+30 days) apart and delivered percutaneously into biopsied and non-biopsied contralateral kidneys...

Active, not recruiting
Enrolling
Chronic Kidney Diseases
Type 2 Diabetes Mellitus
Biological: Renal Autologous Cell Therapy (REACT)
Procedure: Sham Comparator

Phase 3

Prokidney

Nashville, Tennessee, United States and 45 other locations

Primary Objective:Evaluate the effect of Hectorol® capsules in reducing elevated levels of intact parathyroid hormone (iPTH).Secondary Objectives:* E...

Active, not recruiting
Secondary Hyperparathyroidism-Chronic Kidney Disease
Drug: Doxercalciferol (GZ427397)
Drug: Calcitriol

Phase 3

Sanofi
Sanofi

Nashville, Tennessee, United States and 29 other locations

Researchers are looking for a better way to treat people who have non-diabetic chronic kidney disease (non-diabetic CKD). The trial ...

Active, not recruiting
Non-diabetic Chronic Kidney Disease
Drug: Finerenone (BAY94-8862)
Drug: Placebo

Phase 3

Bayer
Bayer

Nashville, Tennessee, United States and 312 other locations

tolerability, and pharmacokinetics (PK) of VX-147 in adult and pediatric participants with apolipoprotein L1 (APOL1)-mediated proteinuric kidney...

Enrolling
Proteinuric Kidney Disease
Drug: Placebo
Drug: VX-147

Phase 2, Phase 3

Vertex Pharmaceuticals
Vertex Pharmaceuticals

Nashville, Tennessee, United States and 236 other locations

The researchers are doing this study to see if semaglutide can slow down the growth and worsening of chronic kidney disease in peop...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Placebo (semaglutide)
Drug: Semaglutide

Phase 3

Novo Nordisk
Novo Nordisk

Nashville, Tennessee, United States and 407 other locations

savolitinib, is effective in treating patients with MET-driven PRCC, how it compares with another medication frequently used to treat this disease...

Active, not recruiting
Kidney Diseases
Kidney Neoplasms
Drug: Savolitinib
Drug: Sunitinib

Phase 3

AstraZeneca
AstraZeneca

Nashville, Tennessee, United States and 58 other locations

The purpose of this single-arm interventional study is to evaluate the long-term safety, efficacy, and durability of the Symplicity Spyral system in...

Enrolling
Chronic Kidney Diseases
Cardiovascular Diseases
Device: Renal Denervation (Symplicity Spyral™)
Medtronic
Medtronic

Nashville, Tennessee, United States and 83 other locations

The purpose of this study is to assess cognitive outcome and quality of life in stable renal transplant patients treated with twice daily tacrolimus...

Enrolling
Renal Transplant
Drug: Change from Prograf to Envarsus XR

Phase 4

Vanderbilt University Medical Center
Vanderbilt University Medical Center

Nashville, Tennessee, United States

Locations recently updated

or more. People can take part if they have cardiovascular or chronic kidney disease. People who have at least 2 health problems rel...

Enrolling
Obesity
Drug: Placebo
Drug: survodutide

Phase 3

Boehringer Ingelheim
Boehringer Ingelheim

Nashville, Tennessee, United States and 512 other locations

5 years post-transplant \~10% of patients will have advanced renal disease that may require renal replacement therapy and/or kidney...

Invitation-only
Lung Transplant; Complications
Drug: Tacrolimus
Drug: Mycophenolate Mofetil Hydrochloride

Early Phase 1

Vanderbilt University Medical Center
Vanderbilt University Medical Center

Nashville, Tennessee, United States

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems